MD, PhD
Professor, Division of Infectious Diseases
Director, Immunocompromised Host Infectious Diseases Section
UNC-Chapel Hill
Immunology
Area of Interest
David van Duin, MD, PhD, is the founding director of the Immunocompromised Host ID service. His main research interests are multi-drug resistant Gram-negative bacteria, and infections in immunocompromised patients.
Awards and Honors
- Highly Cited Researchers (Top 1%), Web of Science, Clarivate Analytics, 2023
News and Stories
![Headshots of the 12 UNC Lineberger members who are listed on Clarivate’s 2023 Highly Cited Researchers list.](https://unclineberger.org/wp-content/uploads/sites/867/2023/11/Clarivate-2023-Highly-Cited-Researchers-feature-600x400.jpg)
UNC Lineberger faculty named world’s most highly cited researchers
Twelve UNC Lineberger Comprehensive Cancer Center members were named to Clarivate’s 2023 Highly Cited Researchers™ list, which recognized scientists who published papers that ranked in the top 1% of cited publications in their field between 2012-2022.
![A microscopic view of MRSA bacteria invading human cells during infection.](https://unclineberger.org/wp-content/uploads/sites/867/2023/10/van-Duin-research-feature-MRSA-bacteria-600x400.gif)
Treatment-resistant infections, a “slow-moving catastrophe”
David van Duin, MD, PhD, and colleagues at UNC-Chapel Hill are working to understand and mitigate the global rise of untreatable infections.